Regulatory science accelerates the development of biotechnology drugs and vaccines by NIFDC

Abstract

The Chinese National Institutes for Food and Drug Control (NIFDC) is the national laboratory responsible for the quality control of pharmaceutical products. In recent years, to ensure the quality of biological products and improve the research and development (R&D) of new biological drugs and vaccines, NIFDC conducted a series of regulatory science studies on key technologies for quality control and evaluation, and established a quality control and evaluation platform for biological drugs and vaccines. These studies accelerated the R&D of the biological drugs and vaccines in China and assured their safety and efficacy. In this paper, NIFDC's duties and achievements in the biological drug and vaccine field are summarized.

The Relationship Between the Genetic Marker DIK20 and A Range of Physiological and Productive Traits in Holstein Cattle

“…Studies have utilized this technology as genetic markers for selection, particularly for traits with low heritability controlled by multiple genetic sites known as quantitative traits loci (QTL), as well as economic traits (Alsaffar, 2022). One of the techniques dependent on the polymerase chain reaction is microsatellites, commonly used in genetic research and molecular marker studies, extending beyond genetic fields (Liang et al, 2014b). Microsatellites are employed in animals to assess genetic variance within breeds (Kunene et al, 2014).…”

The development of China’s vaccine industry in the past decade: the perspective from drug regulatory science

“…The National Institute for Food and Drug Control (NIFDC) has gradually established a bacterial/virus seed bank in line with international standards, and established a research and supply platform, quality evaluation standards and technology platform for biological products, so as to smooth the process of R&D, storage, sales and use of reference materials. 18 There are nearly 40 kinds of reference materials related to vaccine quality control in the catalog of national reference material for biological products (3801) in the volume 3 of Ch.P. 2020 version, such as the national reference materials for evaluating the potency of H7N9 vaccine, 19 and the reference materials used for determining the control of vero cell host DNA residues in human vaccines, 20 etc.…”